CELZ stock news · Creative Medical Technology Holdings, Inc.
Get alerts for CELZ
Follow Creative Medical Technology Holdings, Inc. (CELZ) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for CELZCreative Medical Technology Holdings, Inc. has agreed to buy 80% of BioDefense, Inc. shares.
NeutralCELZ now owns 80% of BioDefense after paying cash and issuing shares. The filing gives no details on BioDefense's business, so the deal does not show whether it helps CELZ.
12 health care stocks changed a lot during Monday's after-hours trading.
NeutralCreative Medical Tech shares rose 5.47% to $1.06 after hours, but the article only lists the price move and market cap, not business news.
Following a significant patent victory, Creative Medical Technology Holdings Inc. sees its stock soar by more than 104%.
NeutralCreative Medical Technology Holdings Inc. experienced a substantial stock surge of over 104% following the announcement of a key patent win, which enhances its intellectual property protection for its innovative diabetes treatment technology. This milestone is expected to bolster the company's market position and attract investor interest.